Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai
$125M sweet spot round size
2018
$125M
from 3 investors over 1 rounds
Paige raised $125M on February 14, 2021
Investors: Kohlberg Kravis Roberts, Johnson & Johnson Innovation – JJDC and + 3 Other investors